The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. European Journal of Neuroscience, 20, 947-955 (2004).In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. The RECIPIENT is required to obtain prior written consent form DEPOSITOR on use of the BIOLOGICAL RESOURCE. C(3〜6か月) true C (3-6 months) Shigetada NAKANISHI C57BL/6Jとのバッククロス9世代目。 中西 重忠 条件を付加する。利用者は事前に寄託者の提供承諾書を得る。<br>研究成果の公表にあたって寄託者の指定する文献を引用する。European Journal of Neuroscience, 20, 947-955 (2004).<br>研究成果の公表にあたって謝辞の表明を必要とする。<br>提供承諾書を必要とする。 Neurobiology Research <a href='https://brc.riken.jp/mus/pcr01271'>Genotyping protocol -PCR-</a> 国立大学法人京都大学 B6;129S6-Grm1<tm1Nak>/NakRbrc 参考文献参照。 Necessary documents for ordering:<ol><li>Approval form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_6.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_d.docx">English</A>)</li><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol> Developed by Drs. Sato Masaaki and Shigetada Nakanishi, Kyoto University Faculty of Medicine in 2004. Kyoto Univ. B6;129-Grm1tm(D854T)/mGluR1TL36 mGliR1TL36 Cell Biology Research RBRC01271 Grm1 (glutamate receptor, metabotropic 1)(mGluR1) knock-in mice, in which aspartate at position 854 was replaced with threonibe (termed D854T). D854T mutant mice homozygous show no obvious behavioural abnormality. mGliR1TL36, B6;129-Grm1<tm(D854T)>/mGluR1TL36 mouse glutamate receptor, metabotropic 1 genomic DNA, phage P1 loxP 特になし。